Lam Research Corporation LRCX Surges On Record Q3 Earnings Beat And Robust Forward Guidance Boeing Co TXT Turnaround Progress Shifting From Existential Crisis to Operational Efficiency Prioritization SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading